Hence, the elevated levels of KL-6 in plasma/serum in patients with pulmonary disease does not seem capable of distinguishing between the underlying condition, and its usefulness in ARDS is unclear with the currently available data. The gene discussed is MUC1; the disease is acute respiratory distress syndrome.